Home/Filings/4/0000914190-16-000915
4//SEC Filing

BIO-TECHNE Corp 4

Accession 0000914190-16-000915

$TECHCIK 0000842023operating

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 4:30 PM ET

Size

18.4 KB

Accession

0000914190-16-000915

Insider Transaction Report

Form 4
Period: 2016-11-29
Transactions
  • Sale

    Common Stock

    2016-11-29$106.73/sh1,000$106,7331,973 total
Holdings
  • Stock Option (right to buy)

    Exercise: $61.46From: 2010-10-28Exp: 2020-10-27Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    Exercise: $65.47From: 2008-10-23Exp: 2018-10-22Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    Exercise: $87.34From: 2016-10-29Exp: 2025-10-28Common Stock (4,260 underlying)
    4,260
  • Stock Option (right to buy)

    Exercise: $91.78From: 2014-10-30Exp: 2024-10-30Common Stock (4,000 underlying)
    4,000
  • Stock Option (right to buy)

    Exercise: $87.39From: 2013-10-31Exp: 2023-10-30Common Stock (4,000 underlying)
    4,000
  • Stock Option (right to buy)

    Exercise: $63.03From: 2009-10-29Exp: 2019-10-28Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    Exercise: $101.19Exp: 2026-10-26Common Stock (3,985 underlying)
    3,985
  • Stock Option (right to buy)

    Exercise: $66.59From: 2007-10-25Exp: 2017-10-24Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    Exercise: $66.90From: 2012-10-25Exp: 2022-10-24Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    Exercise: $70.35From: 2011-10-27Exp: 2021-10-26Common Stock (5,000 underlying)
    5,000
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.54 to $106.90 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The option vests on the earlier of the one year anniversary of the grant date (10/27/17) or the date of Bio-Techne's 2017 annual meeting of shareholders.

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0000842023

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:30 PM ET
Size
18.4 KB